Diabetes Mellitus
Endocrinology Research Centre (Moscow); Russian Association of Endocrinology (Moscow) ISSN 2072-0351
Dergi hakkında
The “Diabetes Mellitus” is a peer-reviewed research and clinical journal published quarterly since 1998 under the auspices of Russian Association of Endocrinologists and Federal Endocrinology Research Centre (Moscow).
Its content focuses on original papers on clinical, experimental and academic studies, but also includes literature reviews, lectures, case studies and supplementary materials. General discourse of the journal is dedicated to the key aspects of diabetology, encompassing etiology, epidemiology and pathogenesis of diabetes mellitus, novel diagnostic and therapeutic methods, as well as prevention and management of acute and late complications of diabetes mellitus and associated conditions.
The intended primary audience of the journal is medical professionals (including diabetologists, endocrinologists, general practitioners, family physicians and pediatricians), scientists and academicians working in the area of endocrinology and diabetology.
In 2014 “Diabetes Mellitus” has become fully bilingual, now featuring full-text English versions of all published materials, and adopted the Gold Open Access distribution model.
The current editorial board understanding of the journal’s mission is as following:
- to facilitate the exchange of clinical experience and scientific data between Russian-speaking and international diabetology communities;
- to inform Russian-speaking medical professionals about the relevant and high-quality evidence-based clinical data.
- Editör
- LLC "UP Print"
- Yayın dilleri
- English, Russian
- Yer aldığı dizinler
- DOAJ –The Directory of Open Access Journals
- EBSCOhost
- Scholar Google
- Scopus
- Ulrich's Periodicals Directory
Makaleler 1.112
Filtrele ve sıralaHistory of the development of endocrinology in the Republic of Tatarstan
Cilt 2014/17, Sayı 2-legacy-1323
Hormonal, electrolyte disturbances and features of hemostasis in term newborn infants of mothers with gestational diabetes mellitus.
Cilt 2015/18, Sayı 1-legacy-1326
Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
Cilt 2014/17, Sayı 1-legacy-1322
Hyperglycaemia in criticaly ill patients
Cilt 2015/18, Sayı 1-legacy-1326
Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
Cilt 2014/17, Sayı 1-legacy-1322
Ileal transposition in surgical treatment for type 2 diabetes mellitus
Cilt 2015/18, Sayı 1-legacy-1326
Immunohystochemical study of the largest islets of human pancreas in aging and diabetes mellitus: perspectives for the transplantation
Cilt 2013/16, Sayı 4-legacy-1320
Incidence of sleep apnea in patients with various types of glycemic disturbances
Cilt 2013/16, Sayı 1-legacy-1317
Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
Cilt 2012/15, Sayı 4-legacy-1316
Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia
Cilt 2014/17, Sayı 4-legacy-1325
Initiation and intensification of antihyperglycemic therapy in type 2 diabetes mellitus: Update of Russian Association of Endocrinologists expert consensus document (2015)
Cilt 2015/18, Sayı 1-legacy-1326
In memoriam: Viktor Vasil'evich Trusov
Cilt 2012/15, Sayı 4-legacy-1316
In Memorian: Harry Keen (3.09.1925–5.04.2013)
Cilt 2013/16, Sayı 3-legacy-1319
In memory of Andrey A. Aleksandrov (1946–2015)
Cilt 2015/18, Sayı 1-legacy-1326
In memory of Vitaly R. Klyachko
Cilt 2014/17, Sayı 4-legacy-1325
Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
Cilt 2014/17, Sayı 4-legacy-1325
Insulin degludec is a new ultra-long-acting insulin analogue
Cilt 2014/17, Sayı 2-legacy-1323
Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
Cilt 2014/17, Sayı 4-legacy-1325
Insulin resistance as a systemic player in renal pathology: a review
Cilt 2014/17, Sayı 1-legacy-1322
Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
Cilt 2013/16, Sayı 1-legacy-1317
Insulin/weight ratio may serve as a predictor of success during insulin pump therapy in type 2 diabetes patients: a proof-of-concept study
Cilt 2015/18, Sayı 1-legacy-1326
Itopride hydrochloride efficacy in the management of delayed gastric emptying in type 1 diabetis mellitus patients in the presence of autonomic neuropathy
Cilt 2014/17, Sayı 3-legacy-1324
Kidneys cytomembranes stability in pregnant women with type 1 diabetes and pregnancy outcomes dependingon the method of insulin delivery
Cilt 2012/15, Sayı 4-legacy-1316
Lack of association between KCNJ11 (rs5219) and ABCC8 (rs757110) polymorphisms and sulphonylurea treatment response in type 2 diabetes patients in Novosibirsk region
Cilt 2015/18, Sayı 1-legacy-1326
Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents
Cilt 2014/17, Sayı 2-legacy-1323